|
Studies of Frontal Lobe Brain Functioning in Schizophrenia Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Studies of Frontal Lobe Brain Functioning in Schizophrenia conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Studies of Frontal Lobe Brain Functioning in Schizophrenia Clinical research trials and Studies of Frontal Lobe Brain Functioning in Schizophrenia healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Studies of Frontal Lobe Brain Functioning in Schizophrenia. Studies of Frontal Lobe Brain Functioning in Schizophrenia Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Studies of Frontal Lobe Brain Functioning in Schizophrenia clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Studies of Frontal Lobe Brain Functioning in Schizophrenia condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Studies of Frontal Lobe Brain Functioning in Schizophrenia  Studies of Frontal Lobe Brain Functioning in Schizophrenia
Studies of Frontal Lobe Brain Functioning in Schizophrenia
For Condition: Healthy,Schizophrenia
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this study is to use brain imaging technology to investigate the role of the frontal lobe of the brain in the thinking of individuals with schizophrenia and other neuropsychiatric disorders and healthy volunteers. Participants in this study will undergo a positron emission tomography (PET) scan of the brain while performing neuropsychological tests. Some of the tests involve cognitive operations that depend upon the frontal cortex. Interactions between frontal lobe activation, cognitive behavior, and neuropharmacology will be assessed by measuring regional cerebral blood flow (rCBF) during treatment with drugs that may affect frontal lobe physiology.
Details: The purpose of this work is to investigate the role of the frontal lobe, and its connections, for cognition in health and in neuropsychiatric diseases, particularly schizophrenia. Regional cerebral blood flow (rCBF) will be measured with oxygen-15 water positron emission tomography (PET) while subjects perform a variety of neuropsychological tests. Some of these tests involve cognitive operations that are posited to depend upon the frontal cortex, such as the use of working memory for abstract reasoning and problem solving, formation and maintenance of conceptual sets, set shifting, sequencing, and delayed response; others control for nonspecific sensory and motor aspects of these measurements or are contrast conditions posited to depend on other brain regions. Interactions between regional activation, cognitive behavior, and neuropharmacology will be assessed by measuring cognitively-related rCBF during treatment with drugs that may affect frontal lobe physiology.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Control subjects with history of psychiatric or neurologic disorders or medical illness or surgeries that might have relevance to the investigation of brain physiology will be excluded. Normal subjects taking medications with relevance to cerebral blood flow and metabolism will be excluded from study. Patients with schizophrenia will be recruited from the inpatient population of the NIMH at NIH. Patients with history of neurological illness other than those of interest to the study, or other medical illness or surgery that might have impact on the study of brain physiology, will be excluded. Additional neuropsychiatric patients (those with affective disorder, Tourette's Syndrome, Huntington's Disease, Parkinson's Disease, Alzheimer's Disease, special genetic disorders (e.g. William's Syndrome), and other neuropsychiatric patients) will be recruited from the medical community, from NIH inpatient and outpatient services, and through the National Alliance for the Mentally Ill (NAMI). All subjects will be asked to refrain from nicotine and caffeine for four hours prior to the PET scan. In the case of female subjects of childbearing age and potential, a urine pregnancy test will be obtained within 24 hours prior to the PET scan. Subjects will be queried for history of metal objects in the head or neck and for other contraindications as listed in the consent form and will only be studied if such history is negative. To acclimate subjects to the testing procedure and to ensure comprehension and ability to cooperate with the study, subjects will practice all tasks, except those to which they must be naive, with equipment similar to that used during the PET scan. In particular, psychotic patients or those for whom cooperation is otherwise difficult will be further screened and acclimated with a "dry run" in the PET scanner. Subjects who are unable to cooperate will be excluded from the study.
Total Enrollment: 660
Location and Contact Information:
National Institute of Mental Health (NIMH) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting E. Riley 8886746464
Additional Information:
Study ID Numbers: 900014; 90-M-0014
Study Start Date: October 26, 1989
Record last reviewed: November 4, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001258
Other Healthy Studies:
1. Brain Activity During Production of Movement
2. Influence of Genetics in Pain Sensitivity
3. The Role of Cyclooxygenase Activity in the Endothelial Function of Hypertensive and Hypercholesterolemic Patients
4. Pilot Study: Effects of G-CSF on T Cell Function
5. Magnetic Resonance Imaging (MRI) of Normal Volunteers
Related Studies:
Other Healthy Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Studies of Frontal Lobe Brain Functioning in Schizophrenia
|
|
|
|
|
|
|
|
